InMode (INMD) Competitors $18.38 +0.14 (+0.77%) (As of 09:45 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOptions ChainOwnershipShort InterestTrends INMD vs. BLFS, NTUS, AXGN, OM, INSP, PRCT, AXNX, NVST, NARI, and LIVNShould you be buying InMode stock or one of its competitors? The main competitors of InMode include BioLife Solutions (BLFS), Natus Medical (NTUS), AxoGen (AXGN), Outset Medical (OM), Inspire Medical Systems (INSP), PROCEPT BioRobotics (PRCT), Axonics (AXNX), Envista (NVST), Inari Medical (NARI), and LivaNova (LIVN). These companies are all part of the "medical" sector. InMode vs. BioLife Solutions Natus Medical AxoGen Outset Medical Inspire Medical Systems PROCEPT BioRobotics Axonics Envista Inari Medical LivaNova BioLife Solutions (NASDAQ:BLFS) and InMode (NASDAQ:INMD) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, valuation, dividends, media sentiment, community ranking, profitability, earnings and institutional ownership. Does the media favor BLFS or INMD? In the previous week, BioLife Solutions had 29 more articles in the media than InMode. MarketBeat recorded 30 mentions for BioLife Solutions and 1 mentions for InMode. InMode's average media sentiment score of 0.51 beat BioLife Solutions' score of 0.49 indicating that InMode is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment BioLife Solutions 7 Very Positive mention(s) 9 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral InMode 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk & volatility, BLFS or INMD? BioLife Solutions has a beta of 1.88, indicating that its share price is 88% more volatile than the S&P 500. Comparatively, InMode has a beta of 2.15, indicating that its share price is 115% more volatile than the S&P 500. Which has preferable earnings & valuation, BLFS or INMD? InMode has higher revenue and earnings than BioLife Solutions. BioLife Solutions is trading at a lower price-to-earnings ratio than InMode, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioLife Solutions$143.27M7.96-$66.43M-$1.06-23.19InMode$492.05M3.14$197.92M$1.859.94 Is BLFS or INMD more profitable? InMode has a net margin of 36.26% compared to BioLife Solutions' net margin of -38.98%. InMode's return on equity of 21.46% beat BioLife Solutions' return on equity.Company Net Margins Return on Equity Return on Assets BioLife Solutions-38.98% -6.61% -5.54% InMode 36.26%21.46%19.19% Do analysts rate BLFS or INMD? BioLife Solutions currently has a consensus price target of $27.50, indicating a potential upside of 11.88%. InMode has a consensus price target of $22.60, indicating a potential upside of 22.96%. Given InMode's higher possible upside, analysts clearly believe InMode is more favorable than BioLife Solutions.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioLife Solutions 0 Sell rating(s) 0 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 3.00InMode 0 Sell rating(s) 4 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.33 Does the MarketBeat Community favor BLFS or INMD? BioLife Solutions received 148 more outperform votes than InMode when rated by MarketBeat users. However, 73.73% of users gave InMode an outperform vote while only 67.25% of users gave BioLife Solutions an outperform vote. CompanyUnderperformOutperformBioLife SolutionsOutperform Votes30867.25% Underperform Votes15032.75% InModeOutperform Votes16073.73% Underperform Votes5726.27% Do institutionals & insiders have more ownership in BLFS or INMD? 93.2% of BioLife Solutions shares are owned by institutional investors. Comparatively, 68.0% of InMode shares are owned by institutional investors. 2.2% of BioLife Solutions shares are owned by insiders. Comparatively, 6.9% of InMode shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. SummaryInMode beats BioLife Solutions on 12 of the 18 factors compared between the two stocks. Ad DTIDownload Our Tesla Ebook For FreeLike many of you, we here at the TradingPub are bullish on Tesla long term. We believe the company will continue to be a leader in technology, EVs and A.I. We also believe it’s share price will be rewarded in a big way… In fact, our #1 Tesla expert just published a brand new Ebook regarding Tesla’s future, and we’d like to send it to you at no cost.To claim your copy free of charge simply follow this link. Get InMode News Delivered to You Automatically Sign up to receive the latest news and ratings for INMD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart INMD vs. The Competition Export to ExcelMetricInModeElectromedical equipment IndustryMedical SectorNASDAQ ExchangeMarket Cap$1.49B$3.44B$5.07B$8.89BDividend YieldN/A1.70%4.99%4.07%P/E Ratio9.8610.8783.5712.93Price / Sales3.1192.821,220.3088.33Price / Cash8.0147.0339.4636.25Price / Book2.083.926.936.25Net Income$197.92M$92.21M$119.12M$225.93M7 Day Performance-4.00%-3.40%-1.83%-1.32%1 Month Performance1.73%6.80%-3.64%0.60%1 Year Performance-18.93%17.06%31.64%26.23% InMode Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)INMDInMode2.3243 of 5 stars$18.38+0.8%$22.60+23.0%-19.3%$1.54B$492.05M9.94480BLFSBioLife Solutions0.8729 of 5 stars$24.58-1.7%$27.50+11.9%+86.5%$1.14B$143.27M0.00409Analyst ForecastInsider TradeAnalyst RevisionNTUSNatus MedicalN/A$32.96flatN/A+0.0%$1.14B$473.44M89.081,400Analyst ForecastAXGNAxoGen2.7099 of 5 stars$12.73-1.3%$15.00+17.8%+113.2%$560.25M$159.01M0.00426OMOutset Medical2.5666 of 5 stars$0.71-1.7%$4.70+558.7%-86.5%$37.49M$130.38M0.00520INSPInspire Medical Systems4.9104 of 5 stars$183.55-0.7%$233.58+27.3%+29.2%$5.50B$624.80M172.781,011Analyst UpgradePositive NewsGap UpPRCTPROCEPT BioRobotics1.5867 of 5 stars$93.13+0.5%$89.50-3.9%+180.7%$4.86B$136.19M0.00626AXNXAxonics3.2587 of 5 stars$70.98flat$71.00+0.0%N/A$3.63B$366.38M-591.45610News CoverageNVSTEnvista3.6426 of 5 stars$20.37+0.5%$20.71+1.7%-14.3%$3.51B$2.57B-2.6212,800NARIInari Medical3.2625 of 5 stars$49.00-3.9%$58.89+20.2%-15.9%$2.87B$493.63M0.001,300Insider TradePositive NewsLIVNLivaNova4.1794 of 5 stars$49.79-0.5%$69.17+38.9%+6.8%$2.70B$1.15B119.172,900 Related Companies and Tools Related Companies BLFS Alternatives NTUS Alternatives AXGN Alternatives OM Alternatives INSP Alternatives PRCT Alternatives AXNX Alternatives NVST Alternatives NARI Alternatives LIVN Alternatives Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:INMD) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding InMode Ltd. Please log in to your account or sign up in order to add this asset to your watchlist. Share InMode With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free INMD Stock Alerts